Advanced search
Publication Cover
Journal of Asthma Volume 61, 2024 - Issue 4
Submit an article Journal homepage
807
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Cost effectiveness of omalizumab for severe asthma in Colombia

Jefferson Antonio Buendíaa Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK;b Research group in Pharmacology and Toxicology, Department of Pharmacology and Toxicology, University of Antioquia, Medellín, ColombiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2404-6612View further author information
, MD PhDORCID Icon,
Diana Guerrero Patiñob Research group in Pharmacology and Toxicology, Department of Pharmacology and Toxicology, University of Antioquia, Medellín, ColombiaView further author information
, RN, MSC &
Andrés Felipe Zuluaga Salazarb Research group in Pharmacology and Toxicology, Department of Pharmacology and Toxicology, University of Antioquia, Medellín, Colombia;c Laboratorio Integrado de Medicina Especializada (LIME), Facultad de Medicina, IPS Universitaria, Universidad de Antioquia, Antioquia, ColombiaView further author information
, MD MSc
Pages 292-299 | Received 10 Aug 2023, Accepted 01 Oct 2023, Published online: 10 Oct 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.